Xeris Biopharma Holdings, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
XERS Nasdaq 2834 www.xerispharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Xeris Biopharma Holdings, Inc.

Xeris Biopharma (XERS) Is Down 9.3% After XP-8121 Patent Milestone Is Announced – Has The Bull Case Changed? - Dec 6th, 2025 2:09 am
What Analysts Think Is Changing The Story For Xeris Biopharma Holdings - Dec 3rd, 2025 9:10 am
Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application - Dec 1st, 2025 5:00 am
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Nov 9th, 2025 5:29 am
Xeris Biopharma (XERS) Reports Q3 Earnings: What Key Metrics Have to Say - Nov 6th, 2025 7:30 am
Xeris Biopharma (XERS) Q3 2025 Earnings Transcript - Nov 6th, 2025 7:16 am
Xeris Biopharma (XERS) Reports Break-Even Earnings for Q3 - Nov 6th, 2025 6:30 am
Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025 - Nov 6th, 2025 5:00 am
Plus Therapeutics (PSTV) Reports Q3 Loss, Lags Revenue Estimates - Oct 30th, 2025 4:45 pm
How Phase 3 XP-8121 Progress at Xeris Biopharma Holdings (XERS) Has Changed Its Investment Story - Oct 28th, 2025 8:11 am
Xeris Biopharma (XERS): Evaluating Valuation as Revenue Growth and Pipeline Advances Spark Renewed Optimism - Oct 27th, 2025 7:07 pm
Xeris Biopharma to Report Third Quarter 2025 Financial Results on November 6, 2025 - Oct 23rd, 2025 5:30 am
Are You Looking for a Top Momentum Pick? Why Xeris Biopharma (XERS) is a Great Choice - Oct 20th, 2025 10:00 am
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct 3rd, 2025 2:15 pm
Xeris Biopharma (XERS) is a Great Momentum Stock: Should You Buy? - Oct 3rd, 2025 10:00 am
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS): Are Analysts Optimistic? - Oct 3rd, 2025 8:03 am
Xeris Biopharma Holdings, Inc. (XERS) Hits Fresh High: Is There Still Room to Run? - Oct 3rd, 2025 7:15 am
What Makes Xeris Biopharma (XERS) a Strong Momentum Stock: Buy Now? - Sep 9th, 2025 10:00 am
Xeris Biopharma Holdings, Inc. (XERS) Reports Record $71.5M Q2 Revenue - Aug 29th, 2025 3:09 am
Xeris Announces Orange Book Listing of U.S. Patent for Recorlev® - Aug 25th, 2025 5:00 am